Clinical Perspectives on Antidepressant Drug Development: A Critical Discussion

E-ISSN： 1873-4286|11|2|227-231

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.2, 2005-01, pp. : 227-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic and Pharmacodynamic Perspectives on the Clinical Drug Development of Panitumumab

By Yang Bing-Bing Lum Peggy Chen Alin Arends Rosalin Roskos Lorin Smith Brian Ruixo Juan José Pérez

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 729-740

Adis International

Access to resources Recommend Favorite

Antidepressant therapy: new targets for drug development

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 11, 2001-11 ,pp. : 1693-1711

Informa Healthcare

Access to resources Recommend Favorite

Discussion of the “Executive Summary of the PhRMA Working Group on Adaptive Designs in Clinical Drug Development”

By Lokhnygina Yuliya

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 287-288

Taylor & Francis Ltd

Access to resources Recommend Favorite

Discussion of “Executive Summary of the PhRMA Working Group on Adaptive Designs in Clinical Drug Development”

By Wassmer Gernot

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 289-291

Taylor & Francis Ltd

Access to resources Recommend Favorite

Discussion of “Executive Summary of the PhRMA Working Group on Adaptive Designs in Clinical Drug Development”

By Jennison Christopher

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 293-298

Taylor & Francis Ltd

Access to resources Recommend Favorite